These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17346103)

  • 1. Oncolytic viruses: what's next?
    Bell JC
    Curr Cancer Drug Targets; 2007 Mar; 7(2):127-31. PubMed ID: 17346103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.
    Wei D; Xu J; Liu XY; Chen ZN; Bian H
    Hum Gene Ther; 2018 Feb; 29(2):151-159. PubMed ID: 29284308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in oncolytic virus-based cancer therapy.
    Fu LQ; Wang SB; Cai MH; Wang XJ; Chen JY; Tong XM; Chen XY; Mou XZ
    Virus Res; 2019 Sep; 270():197675. PubMed ID: 31351879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic viruses: perspectives on clinical development.
    Burke J; Nieva J; Borad MJ; Breitbach CJ
    Curr Opin Virol; 2015 Aug; 13():55-60. PubMed ID: 25989094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade.
    Marchini A; Scott EM; Rommelaere J
    Viruses; 2016 Jan; 8(1):. PubMed ID: 26751469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.
    Wennier ST; Liu J; McFadden G
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1817-33. PubMed ID: 21740354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potency of oncolytic virotherapy in breast cancer targeting, current status and perspective.
    Ebrahimi S; Ghorbani E; Shafiee M; Ryzhikov M; Hassanian SM; Azadmanesh K
    J Cell Biochem; 2019 Mar; 120(3):2801-2809. PubMed ID: 30260014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses.
    Cassady KA; Haworth KB; Jackson J; Markert JM; Cripe TP
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26861381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-oncogenic cell signaling machinery as a target for oncolytic viruses.
    Borrego-Diaz E; Mathew R; Hawkinson D; Esfandyari T; Liu Z; Lee PW; Farassati F
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1742-9. PubMed ID: 21740363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical development of oncolytic viruses in China.
    Liang M
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1852-7. PubMed ID: 21740357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic viruses and histone deacetylase inhibitors--a multi-pronged strategy to target tumor cells.
    Nguyen TL; Wilson MG; Hiscott J
    Cytokine Growth Factor Rev; 2010; 21(2-3):153-9. PubMed ID: 20395162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].
    Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies.
    Gujar S; Pol JG; Kim Y; Lee PW; Kroemer G
    Trends Immunol; 2018 Mar; 39(3):209-221. PubMed ID: 29275092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of oncolytic viruses.
    Sanjuán R; Grdzelishvili VZ
    Curr Opin Virol; 2015 Aug; 13():1-5. PubMed ID: 25699475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics.
    Harrington KJ; Vile RG; Melcher A; Chester J; Pandha HS
    Cytokine Growth Factor Rev; 2010; 21(2-3):91-8. PubMed ID: 20223697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial overview: Oncolytic viruses--replicating virus therapeutics for the treatment of cancer.
    Bell JC; McFadden G
    Curr Opin Virol; 2015 Aug; 13():viii-ix. PubMed ID: 26260227
    [No Abstract]   [Full Text] [Related]  

  • 18. Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection.
    Bourhill T; Mori Y; Rancourt DE; Shmulevitz M; Johnston RN
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30103501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones.
    Martin NT; Bell JC
    Mol Ther; 2018 Jun; 26(6):1414-1422. PubMed ID: 29703699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM; Bell JC; Vähä-Koskela MJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.